Contract facts
FederalNo full NAICS 325414 intel page yet. Browse NAICS intelligence
1,600 UNITS OF OCTAPLASLG DELIVERED TO BLOOD BANK WEST is a federal award for Defense Health Agency held by Octapharma Usa Inc. Estimated value $1.9M ($1.9M obligated). Current period of performance ends May 29, 2026. Place of performance: PARAMUS NJ. Related solicitation HT942525Q0071.
1,600 UNITS OF OCTAPLASLG DELIVERED TO BLOOD BANK WEST
Recompete timing
PublicCurrent PoP ended May 29, 2026 (84 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordOctapharma Usa Inc — $9.2M obligated across 8 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT942726FE009?
HT942726FE009 (1 600 UNITS of octaplaslg delivered) is a Defense Health Agency award with a potential value of $1.9M, currently held by Octapharma Usa Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded HT942726FE009?
Defense Health Agency awarded HT942726FE009 to Octapharma Usa Inc (potential $1.9M).
Who is the incumbent on HT942726FE009?
Octapharma Usa Inc is the incumbent with $9.2M across 8 related awards in SCOUT’s public footprint. The current period of performance ends May 29, 2026.
When does Octapharma Usa Inc’s HT942726FE009 come up for recompete?
SCOUT tracks a period-of-performance end of May 29, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.